ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 5000 participants.

Also called NCT06676280

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 5,000 participants (planned count) (from the registry)
Sponsor
Jung-min Ahn (from the registry)
Registry
  • NCT NCT06676280
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06676280. Randomized; no masking; primary purpose prevention. Start 2025-07-24 (actual); primary completion 2035-03-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ASpirin Use and stAtin Strategy for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography
Acronym
ASA-3C
Condition
Cardiovascular Diseases
Intervention (Drug)
Aspirin
Intervention (Drug)
High-intensity statin
Intervention (Drug)
Guideline-directed statin therapy
Lead sponsor
Jung-min Ahn (class: other)

Record details

Record id
cardio:ct-nct06676280
Content hash
17fee4ea9d20ffd38aeb185d2e8c492f2ed08e7d9dedba29063dca0129438374